United States · 
What does Zero Stage Capital invest in?
Zero Stage Capital invests most often at Series B and Series C (75% of the rounds on record), in sectors such as Biotechnology, Health Diagnostics and Venture Capital & Private Equity.
Zero Stage Capital highlights
- 01
12 rounds on record
- 02
Mostly Series B and Series C: 75% of its rounds
- 03
Sole investor in 2 rounds, median $4.5M
- 04
4 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyHealth DiagnosticsVenture Capital & Private Equity
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2006
1 round
- Dec
- 2005
1 round
- Apr
- 2004
3 rounds
- Jul
- Jun
- Jan
- 2002
4 rounds
- Dec
- Nov
- Aug
- Jan
- 2001
2 rounds
- Sept
- Feb
- 2000
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed4 in all
BioTroveBought by Life TechnologiesUndisclosedNov 2009
AprilisBought by Dow CorningUndisclosedAug 2006
Pintex PharmaceuticalsBought by VernalisUndisclosedApr 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.